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Abstract: Tissue resources have become an important component of the infrastructure of institutions as well as companies 
performing biomedical research. Such tissue resources may be in the model of a bank, collecting a limited type of tissues 
and processing and storing them following a speciﬁ  c protocol. Such banks or archives may be associated with a clinical 
study or may function indepedently. An alternative type of tissue resource is utilized by many institutions and cancer centers. 
In this model, the investigator speciﬁ  es the methods by which selected tissues are to be collected, processed and stored. In 
such a “prospective model”, initially developed at the University of Alabama at Birmingham and the Ohio State University 
in the late 1970’s and adopted by the Cooperative Human Tissue Network in 1986, speciﬁ  c types of tissues are not collected 
unless requested by an investigator. At some sites, both a prospective and an archival (bank) model are followed. This 
article describes an informatics approach needed to support a prospective tissue resource. It is by necessity more complicated 
than a model which supports a tissue bank but also can be used by a tissue bank. Of great importance is the approach to 
vocabulary and common data elements needed to support the informatics system of a prospective tissue resource, especially 
if the informatics system is to be used by a variety of personnel with greatly varying educational backgrounds.
Introduction
Access to human tissue for research is critical to the success of molecular medicine. The Cooperative 
Human Tissue Network (CHTN) is the only specialized human tissue resource funded by the National 
Cancer Institute
1,2 that focuses on collecting tissue specimens to meet speciﬁ  c requirements, standards 
and requests of investigators. The other specimen resources listed by the National Cancer Institute are 
banks of archived specimens, while the CHTN is unique in that it is designed for prospective collection. 
Prospective collection allows the user to constrain the pre-analytical variables that can affect their 
research results, e.g. exclude radiation therapy in the case of a tissue donor with breast cancer.
The CHTN is comprised of six academic institutions whose mission is to provide remnant human 
solid tissue, ﬂ  uids, and exfoliates to support biomedical researchers throughout the United States and 
Canada. The CHTN provides normal, malignant, benign, and diseased tissue from routine surgical 
resections, autopsies, and a variety of procedures resulting from the collection of body ﬂ  uids. Tissues 
are collected prospectively; and thus as per the investigator’s protocol for collection and for preparation. 
Specimens are typically provided to the researcher as fresh or frozen material, ﬁ  xed tissue embedded 
in parafﬁ  n blocks, parafﬁ  n sections of tissue mounted on microscopic slides, or as thick parafﬁ  n or 
frozen sections of tissues in cryotubes for molecular studies.
Currently, commercial, institutional, and academic researchers submit applications with information 
detailing their tissue requests and collection protocols, funding support, project objectives, and any 
associated institutional approvals required for working with human tissues to the CHTN division that 
services their geographical region. This division becomes known as the primary division for that 
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investigator. Once the application is approved, 
prospective collection begins. If tissues cannot be 
procured for the investigator rapidly by the primary 
division, speciﬁ  cally within a reasonable amount 
of time, typically two weeks, then the request is 
networked to the other divisions. Thus, although 
investigators are assigned to one division, they 
have access to tissue from across the network as 
needed to fulﬁ  ll their requirements. Sharing, updat-
ing and managing investigator requests for tissues 
among the six divisions of the CHTN requires a 
shared, distributed information system and sophis-
ticated informatics support. In the past, the CHTN 
has relied upon stand-alone databases at each 
institution, with a central server for uploading 
networked requests from each division, merging 
these and distributing the merged requests to the 
individual divisions. With the advent of the world 
wide web and secure communications strategies, 
the CHTN has elected to migrate to a centralized 
relational database with web access for its tissue 
request and networking system. Given the complex 
security issues involved with utilizing a centralized 
infrastructure to store information protected by the 
Health Insurance Portability and Accountability 
Act of 1996 (HIPAA), the individual tissue inven-
tories with donor information are maintained 
locally by each division and are not distributed 
unless identifying information is removed (infor-
mation and reports are de-identiﬁ  ed). Fortunately, 
only investigator information needs to be shared 
among divisions and no donor information is 
shared.
Any clinical annotation, such as survival times 
or other follow-up information, is managed by the 
local division. The CHTN provides diagnostic 
information about the tissue as a part of its tissue 
service. Additional information can be requested 
as a chart review. Chart reviews with follow-up 
information requested after the tissue has been 
distributed must follow the guidelines of the local 
Institutional Review Board, such as requiring 
informed consent by the patient for continued 
abstraction of their clinical record.
A database supporting a prospective tissue 
resource includes components related to details on 
the investigators, investigator requests for tissues, 
donor characteristics, specimen information (e.g. 
quality control), storage information on the tissue 
aliquots, integrity of storage conditions such as 
freezer temperature logs and information about 
freezer back-up systems, and the details of transfer 
of tissues/information to the investigator. These 
databases are subject to data integrity recommen-
dations as issued by the National Cancer Institute 
Best Practices for Biospecimen Resources.
3 These 
data integrity recommendations include guidelines 
for back-up systems.
Thus, the informatics tools for the CHTN 
include a resource to enter detailed tissue requests, 
as well as to retrieve investigator information about 
tissue requests in order to drive tissue collection. 
Also the system must be able to network (share) 
tissue requests, and to exchange information with 
a tissue inventory system containing donor infor-
mation. The informatics requirements for this 
prospective collection model extend beyond the 
speciﬁ  cations of the informatics system used for 
an archival tissue bank. Archival tissue banks are 
typically designed to collect tissue using a limited 
number of standard collection protocols, such as 
snap freezing tissue in OCT using liquid nitrogen 
or the creation of parafﬁ  n embedded formalin ﬁ  xed 
tissue blocks. Searching tools are important for the 
inventory, from which tissue collections will be 
withdrawn post-hoc, based on a sufﬁ  cient number 
of tissues matching the search criteria developed 
by an investigator. As alluded to earlier, the busi-
ness model of a prospective tissue collection also 
requires searching tools for the tissue request sys-
tem in order to anticipate and plan for speciﬁ  c 
needs of future collections.
The inherent design of each component of such 
a database is different; thus, a tissue request data-
base is different from a tissue collection/storage 
database; however, the data elements and allowable 
values for all data elements that are common to the 
components of the database must be consistent to 
permit effective communication. Similarly, if dif-
ferent organizations want to have their databases 
to communicate, standardization of data elements 
(common data elements) across organizations 
would be critical to effective communication.
Recently, the National Cancer Institute, in rec-
ognition of a need for common data elements for 
computer systems so that cancer centers and other 
groups of investigators can exchange large volumes 
of data, instituted the Cancer Bioinformatics Grid 
(CaBIG) projects to provide standards for data 
exchange in cancer research.
4–10 They also were to 
develop and provide a variety of generic software 
systems and tools to assist in compliance with caBIG 
standards. One of the tools currently offered is 
caTissue, a tissue inventory for archived tissue 
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collections. The informatics requirements for the 
CHTN, which centers upon the prospective tissue 
collection model, extend beyond those for caTissue. 
As a result, the CHTN has constructed a comple-
mentary informatics system called TissueQuest© 
for managing tissue requests within the context of 
its business model for prospective collection and 
rapid distribution of tissues.
One of the business requirements for TissueQuest© 
was that it be accessible to a spectrum of users with 
a wide variety of educational backgrounds. The user 
population includes pathologists who oversee and 
provide quality control for the tissue collections, 
division coordinators who manage repository oper-
ations and tissue procurement personnel who collect 
and store the tissue and distribute tissues to research-
ers. In addition, information concerning tissue 
requests that is compatible with the system must be 
obtained from donor records and shared with 
research investigators, ranging from basic scientists 
to physician investigators, as well as their laboratory 
managers who may not have advanced degrees. A 
simpliﬁ  ed ontological approach to the tissue request 
system appropriate for several levels of sophistica-
tion has been developed for this application such that 
it meets the critical requirement that the vocabulary 
be useful over various levels of experience and edu-
cation. The data model incorporating the ontology 
has been constructed using concepts based on 
anatomy, the etiology and the pathophysiology of 
the disease. In addition to meeting its own user 
requirements, the CHTN has worked to remain 
compliant with the complementary efforts of caBIG 
to standardize data elements for tissue collection and 
annotation for neoplastic tissues.
A particular conundrum has been the selection 
of a terminology source for annotation of the tissue. 
There are two perspectives on annotation of tissue. 
One is that it should be based upon an accepted 
standard in disease terminology, such as the Inter-
national Classiﬁ  cation of Diseases (ICD) system, 
or its counterpart for cancer, the Oncology Clas-
siﬁ  cation of Diseases (OCD). The other is that it 
should be based upon an accepted standard in the 
terminology of histopathologic diagnoses, such as 
the College of American Pathologists (CAP) can-
cer protocols or the World Health Organization 
(WHO) histological classiﬁ  cation of tumors. The 
CHTN has adopted the latter approach, which uses 
histological diagnoses as a deﬁ  ning property of 
tissue, while disease terminology is considered a 
property of the patient. This is important in that 
many tissue resources have primary access to the 
surgical pathology report which may or may not 
include information on systemic disease processes 
(e.g. speciﬁ  cally for an invasive tumor from a 
patient with diabetes; thus, the tissue resource is 
unlikely to have information about the patient’s 
systemic disease). The CHTN has further extended 
this concept such that both the tissue request and 
the tissue annotation are based on the histological 
diagnosis. While tissue can be requested from 
patients who have certain characteristics, the tissue 
itself is parent to its histological properties 
and pathophysiological characterization. Non-
histological disease descriptors can be used to 
qualify a histological annotation, such as selecting 
a grade or stage of disease, or to pre-deﬁ  ne the 
donor population, such as patients with breast 
cancer who have a history of ovarian carcinoma.
Having adopted the concept of a histological 
diagnosis as the focal point for both the tissue 
request and the tissue annotation, it is still necessary 
to select a terminology that will become the 
allowable values for the common data elements each 
corresponding to a speciﬁ  c histological diagnosis. 
This issue is complicated because diagnostic 
pathology has suffered from a lack of standards for 
terminology in assigning a diagnosis. For example, 
squamous cell carcinomas of the lung have also been 
called epidermoid carcinomas of the lung. This 
synonymous terminology is a source of difﬁ  culties 
for investigators who use tissues in research and 
bio-specimen repository personnel who are not 
trained in pathology. The problem of choosing a 
terminology is complicated further by the fact that 
there is not always a one-to-one mapping of 
histological disease deﬁ  nitions between terminology 
sources, including the CAP and the WHO, a problem 
that is compounded by the evolution of disease 
organization and terminology over time.
This paper describes both the disease classiﬁ  ca-
tion data model developed for TissueQuest© and 
the approach used in selecting the terminology for 
histological diagnoses. A complete list of allowable 
diagnostic terms for all tissue request categories is 
available in Appendix A which is posted on the 
website.
CHTN Disease Classiﬁ  cation Data 
Model for TissueQuest©
The ontology for the new disease classiﬁ  cation 
system of the CHTN organizes tissue requests at 
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a superﬁ  cial level using a combination based on 
the pathophysiology of the disease, the metadata 
required for making a tissue request, and the types 
of requests commonly encountered by the CHTN. 
The pathologists associated with the CHTN pro-
vide the knowledge basis for the pathophysiology 
of disease; however, the knowledge basis for the 
metadata required for making tissue requests and 
for understanding the types of requests commonly 
encountered results from the over twenty years of 
experience across the network in receiving requests 
for tissues and supplying researchers with appro-
priate tissues. Our experience can be considered 
as the “human factor,” which is critical to the suc-
cess of any informatics system. It insures that the 
system will operate efﬁ  ciently within the context 
of the ﬂ  ow of information that normally occurs 
between an investigator or designate and the per-
sonnel of the tissue resource as they assist the 
investigator in navigating the domain of diagnostic 
pathology with a scientiﬁ  c destination in mind. It 
encompasses knowledge gained from multiple 
decades of experience across the CHTN.
As depicted in Figure 1, there are four broad 
classiﬁ  cations for tissue requests: Normal Tissue 
not related to the patient’s diseases, Tissue from 
patients with a Non-Neoplastic Disease, Tissue, 
diseased and non-diseased, from patients with a 
Neoplastic Disease, and Anything (or Any), which 
is any of these major categories. The role of patho-
physiology in the data model is clear for the normal 
versus diseased categories. The inclusion of a 
category for “Any” or “Anything” is derived from 
the CHTN experience, or the human factor.
As Figure 1 also shows, requests for “Normal 
Tissue” are further subdivided according to 
whether or not co-existing medical conditions are 
acceptable or not, while the Anything category is 
further subdivided into Anything Normal or Abnor-
mal and Anything Abnormal. The Neoplastic 
Human Tissue Requests
Normal
Neoplastic Disease 
Non-neoplastic Disease 
Anything
With co-existing medical condition 
Without co-existing medical condition
Hyperplasia/Metaplasia/Benign Neoplasia
Dysplasia/Pre-malignancy/Indeterminate Malignant Potential
Malignant Neoplasia
Anything Normal or Abnormal 
Restrict to Anything Abnormal
See Table 1 for subclasses of Non-neoplastic disease 
Figure 1. CHTN high level ontology for TissueQuest©.
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Disease Category is further subdivided into the 
following three categories: Benign/Hyperplasia/
Metaplasia, Dysplasia or Neoplasia of Indetermi-
nate (Borderline) Malignancy, which includes 
tumors such as intra-adrenal paragangliomas and 
borderline tumors of the ovary, and frankly Malig-
nant tissues. The Non-neoplastic Disease Catego-
ries are the most numerous and are not depicted in 
Figure 1. These are listed in Table 1. Non-neoplastic 
disease is broken down further by etiology inas-
much as it is understood and by organ site.
The business rules of the CHTN are such that 
all types of tissue requested by a single investiga-
tor are included within a single investigator ﬁ  le 
and within this ﬁ  le, a single request is made up of 
all required requests related to a single organ. For 
example, if the investigator requests ductal carci-
noma of the breast and requires matching normal 
breast tissue, as well as a 0.2 ml of serum from the 
same donor, this would be a single request. If all 
these tissues (e.g. serum) can come from any 
patient, then multiple tissue requests are generated. 
Thus, when generating reports, the tissue collectors 
know that tissues requested within a single tissue 
request must come from the same donor and that 
any number of related specimens within a single 
tissue request must come from the same donor. 
Any number of related specimens or body ﬂ  uid/
exfoliates are allowed. This business rule also 
governs the metadata collected for each tissue 
request, which will be discussed in more detail 
subsequently.
Users ﬁ  rst select a tissue request type from the 
high level ontology classes above: Normal, Neo-
plastic Disease, Non-Neoplastic Disease, and 
Anything. To simplify the system for the coordina-
tors, the menu for tissue type lists the three Neo-
plastic Disease subclasses instead of Neoplastic 
Disease. Thus, coordinators do not have to click 
twice to reach this level.
For Normal and Anything tissue request types, 
the histological diagnosis has already been selected. 
The user then selects solid tissue and/or body ﬂ  u-
ids. The terminology for these will be discussed 
below. In the case of neoplastic diseases, the user 
deﬁ  nes the neoplastic disease of the donor by 
selecting the primary organ site and the disease. 
Again, by experience, a category of “Any” is avail-
able to incorporate requests such as “Malignant 
Tissue, Any Type”. Such requests are sometimes 
made, for example, to test a new antibody. Once 
the disease has been deﬁ  ned, e.g. adenocarcinoma 
of the colon, then the user selects the tissue types 
requested: primary tumor, grossly uninvolved tis-
sue, and/or tumor interface with uninvolved tissue. 
The user can also select another unrelated body 
site for tissue, and/or a metastasis. The list of sites 
for a metastasis selection will be described subse-
quently.
Terminology for Anatomic Sites, 
Sub-sites, and Body Fluids
Non-neoplastic disease is similar to neoplastic 
disease in that the user ﬁ  rst selects the disease, then 
a site (presumed involved) for tissue collection. 
The user is given the option to collect matched 
uninvolved tissue from the same site. The anatomic 
sites and body ﬂ  uids lists will be described in the 
next section.
The selection of the terminology for the tissue 
request types will be discussed following a descrip-
tion of the terminology for the anatomic site, sub-
sites and body ﬂ  uid.
Terminology for Anatomic Sites, 
Sub-sites, and Body Fluids
Anatomic sites and subsites
If solid tissue is selected, then the user is given a 
list of anatomic sites from which to choose. A 
single list of anatomic sites and sub-sites is used 
to characterize solid tissues requests for all types 
of tissue requests except Non-neoplastic disease 
requests, which will be described below. The ana-
tomic site triggers an associated list of subsites. 
The list of anatomic sites and associated sub-
sites is also available on the journal website as 
Appendix B.
The anatomic sites list is built upon the organi-
zation of anatomic sites and associated data ele-
ments in the CAP Cancer protocols, with 
modiﬁ  cations and enhancements to meet the needs 
of the CHTN. For example, to date researchers 
have never speciﬁ  ed laterality in their requests for 
breast or other bilateral tissue, so this has been 
excluded, but could be added if necessary. An 
anatomic site termed vascular, not included in the 
CAP protocols, is given as a choice. It permits a 
number of sub-sites to be speciﬁ  ed including “any” 
or alternatively, a specific artery or vein. For 
example, a portion of a renal artery frequently is 
requested by investigators.
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Table 1. Major disease classes for non-neoplastic 
disease.
Any
Acquired Cysts
Congenital-Developmental
Diseases with Mendelian Inheritance
Ectopic
Infection
Infection-Cardiovascular
Infection-Gastrointestinal Tract
Infection-Peritoneum
Infection-Products of Conception
Infection-Products of Conception
Infection-Prostate
Infection-Pulmonary
Infection-Renal
Infection-Reproductive Tract
Infection-Upper Respiratory Tract
Infection-Vascular
Infection-Specify Site
Inﬂ  ammatory-Non-Infectious
Inﬂ  ammatory-Non-infectious-Allergic
Inﬂ  ammatory-Non-infectious-Allergic-Skin
Inﬂ  ammatory-Non-infectious-Autoimmune
Inﬂ  ammatory-Non-infectious-Autoimmune-
Cardiovascular
Inﬂ  ammatory-Non-infectious-Autoimmune-Endocrine
Inﬂ  ammatory-Non-infectious-Autoimmune-
Hematologic
Inﬂ  ammatory-Non-infectious-Autoimmune-
Hepatobiliary
Inﬂ  ammatory-Non-infectious-Autoimmune-Musculo-
Skeletal
Inﬂ  ammatory-Non-infectious-Autoimmune-Skin
Inﬂ  ammatory-Non-infectious-Automimmune-
Hepatobiliary
Inﬂ  ammatory-Non-infectious-Automimmune-
Systemic/Connective Tissue
Inﬂ  ammatory-Non-infectious-Automimmune-
Systemic/Connective Tissue/Vascular
Inﬂ  ammatory-Non-Infectious-Bone
Inﬂ  ammatory-Non-infectious-Cardiovascular
Inﬂ  ammatory-Non-infectious-Exposure-Pulmonary
Inﬂ  ammatory-Non-Infectious-Gastrointestinal Tract
Inﬂ  ammatory-Non-Infectious-Genitourinary Tract
Inﬂ  ammatory-Non-infectious-Hepatobiliary
Inﬂ  ammatory-Non-infectious-Idiopathic-Endocrine
Inﬂ  ammatory-Non-infectious-Idiopathic-
Gastrointestinal Tract
Inﬂ  ammatory-Non-infectious-Idiopathic-Pulmonary
Inﬂ  ammatory-Non-infectious-Idiopathic-Reproductive 
Tract
(Continued)
Table 1. (Continued)
Inﬂ  ammatory-Non-infectious-Idiopathic-Systemic
Inﬂ  ammatory-Non-infectious-Musculo-Skeletal
Inﬂ  ammatory-Non-infectious-Reproductive Tract
Inﬂ  ammatory-Non-infectious-Salivary Gland
Inﬂ  ammatory-Non-infectious-Skin
Inﬂ  ammatory-Not Speciﬁ  ed by Etiology
Inﬂ  ammatory-Not Speciﬁ  ed by Etiology-
Cardiovascular
Inﬂ  ammatory-Not Speciﬁ  ed by Etiology-Connective 
Tissue
Inﬂ  ammatory-Not Speciﬁ  ed by Etiology-Endocrine
Inﬂ  ammatory-Not Speciﬁ  ed by Etiology-
Gastrointestinal Tract
Inﬂ  ammatory-Not Speciﬁ  ed by Etiology-Genitourinary 
Tract
Inﬂ  ammatory-Not Speciﬁ  ed by Etiology-Musculo-
Skeletal
Inﬂ  ammatory-Not Speciﬁ  ed by Etiology-
Oropharyngeal
Inﬂ  ammatory-Not Speciﬁ  ed by Etiology-Reproductive 
Tract
Inﬂ  ammatory-Not Speciﬁ  ed by Etiology-Respiratory 
Tract
Inﬂ  ammatory-Not Speciﬁ  ed by Etiology-Salivary 
Glands
Liths
Medical Kidney
Neurodegenerative/Neuropsychiatric
Non-inﬂ  ammatory Diseases/Lesions
Non-inﬂ  ammatory Diseases/Lesions-Cardiovascular
Non-inﬂ  ammatory Diseases/Lesions-Gastrointestinal
Non-inﬂ  ammatory Diseases/Lesions-Genitourinary
Non-inﬂ  ammatory Diseases/Lesions-Hepatobiliary
Non-inﬂ  ammatory Diseases/Lesions-Metabolic
Non-inﬂ  ammatory Diseases/Lesions-Metabolic-
Cardiovascular
Non-inﬂ  ammatory Diseases/Lesions-Metabolic-
Musculo-Skeletal
Non-inﬂ  ammatory Diseases/Lesions-Musculo-
Skeletal
Non-inﬂ  ammatory Diseases/Lesions-Ophthalmic
Non-inﬂ  ammatory Diseases/Lesions-Pulmonary
Non-inﬂ  ammatory Diseases/Lesions-Reproductive Tract
Non-inﬂ  ammatory Diseases/Lesions-Skin
Non-inﬂ  ammatory Diseases-Idiopathic-Hematologic
Paraneoplastic Syndromes
Structural-Ectatic-Etiology Not Speciﬁ  ed
Structural-Etiology Not Speciﬁ  ed
Structural-Mechanical-Etiology Not Speciﬁ  ed
Syndromes not well categorized
Transplant Related
Trauma
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The neoplastic or the non-neoplastic disease site 
list for tissues from an unrelated body site uses a 
concatenated list of anatomic sites and subsites. 
The decision to concatenate the two was based on 
a desire to optimize performance and training and 
eliminate triggering of subsequent drop-down lists 
in the software by the tissue request system. This 
performance factor was weighed against making 
lists as short as possible, and therefore easier for 
the end-user to use. This is in contrast to tissue 
requests for normal, anything, or neoplastic dis-
eases where the histology is a function of the 
anatomic site. Therefore, because anatomic site 
was required to trigger the list of possible histolo-
gies, there is no computation time added to trigger 
a list of subsites.
In the case of non-neoplastic disease, the disease 
itself is not always deﬁ  ned by or localized to a 
single organ or tissue type. For example, infections 
can occur in many different sites. Also, an organ 
speciﬁ  c disease such as cardiomyopathy may have 
downstream effects on the liver. Thus, the decision 
was made to minimize the performance time 
required and to use the concatenated anatomic 
site-subsite list. For purposes of illustration, this 
list is given in Appendix C.
Body ﬂ  uids
In addition to solid tissues, the user can request a 
body ﬂ  uid or exfoliate. These lists differ slightly 
between the normal type tissue request and the 
other categories because certain body ﬂ  uids have 
a speciﬁ  c site from which they can be collected, 
e.g. a pleural or pericardial ﬂ  uid. The body ﬂ  uid 
selection list is based on CHTN requests, and uses 
community standard terminology for the topology 
of the ﬂ  uid. The lists of options for Normal and 
the other tissue request types is included in 
Appendix D and on the journal website as supple-
mental data.
Metastatic site selections
For metastatic sites, we created a list with terminol-
ogy compliant with our list of anatomic sites and 
subsites, but based on actual requests to the CHTN. 
An important designation is whether or not only 
metastatic tissue is to be collected, if both primary 
and metastatic tissue are required, or if either pri-
mary or metastatic tissue is needed. Similarly, the 
site of the metastasis may be speciﬁ  ed or alterna-
tively “any” is used as the modiﬁ  er when metastatic 
tissue from any site is acceptable. This is given in 
Appendix E and on the journal website as supple-
mental data.
Terminology for Subsite Qualiﬁ  er 
for Normal and Anything Tissue 
Requests
Investigators often characterize their normal tissue 
requests beyond the level of an anatomic site and 
subsite. For example, only mucosa may be 
requested. In addition, normal tissue under the 
effect of certain hormones might be requested, such 
as lactating breast. The list of subsite qualiﬁ  ers is 
based upon the Normal tissue requests that the 
CHTN has received. As mentioned earlier, the 
subsite qualiﬁ  ers for normal tissue requests are 
included in Appendix A.
Non-neoplastic disease metadata 
and terminology
Non-neoplastic disease is broken down further by 
etiology inasmuch as it is understood and by organ 
site. The main groups are given in Table 1. The 
philosophy has been to extend the complexity of 
the description and narrow the focus on each dis-
ease class during future operations of the CHTN, 
with additional experience causing new tissue 
requests to be incorporated into the database. As 
discussed previously, future plans include the 
development of a concept based interface that 
would enable investigators to browse the selections 
based on some knowledge of the etiology or patho-
physiology of the disease, e.g. an autoimmune 
disease or diseases with Mendelian inheritance 
patterns (e.g. pancreatic tissues from patients with 
cystic ﬁ  brosis).
While this list is not exhaustive, it includes all 
of the disease entities that have been requested to 
date from the CHTN. Addition of new diagnostic 
terms to the database can be easily added to the 
system as needed.
Neoplastic Disease Terminology
General considerations
Neoplastic disease has been subdivided into the 
following three main categories, based upon their 
expected behavior: Benign/Hyperplasia/Metaplasia, 
Dysplasia or Neoplasia of Indeterminate (Borderline) 
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Malignant Potential, or Malignant (frankly so). As 
described earlier, a neoplasia is typically a function 
of its anatomic site except for lymphomas, sarco-
mas and a few other diagnoses. We have created 
this data model using the basic concept that epi-
thelium is specialized for function within an organ 
or anatomic site, and thus an adenocarcinoma of 
the lung is inherently different from an adenocar-
cinoma of the colon. Therefore, disease lists are 
triggered by site. For example, the term “adeno-
carcinoma” may be found for multiple anatomic 
sites. Once selected in combination with an ana-
tomic site, it represents the primary adenocarci-
noma of that organ site. Users may also specify 
any anatomic site and request adenocarcinoma. 
Thus, an adenocarcinoma from any site will be 
procured for the investigator.
In some cases, the organ of origin is not region-
ally delimited with the body, such as hematopoietic 
tissue (e.g. lymphomas) or soft tissue (e.g. liposar-
comas). Neoplasia for these can either be requested 
on a systemic basis, e.g. with soft tissue as the 
anatomic site for sarcoma, or originating in a 
delimited anatomic location, e.g. an angiosarcoma 
of the breast. While there is, in this example, a 
replication of the histological diagnosis term or 
value “angiosarcoma” in both the soft tissue and 
the breast disease lists, the union of the anatomic 
site and the disease itself combines to create unique 
tissue requests: “Breast-Angiosarcoma” versus 
“Soft Tissue-Angiosarcoma” and as such are not 
synonymous. Another possibility would be to 
restrict the angiosarcoma diagnosis to a major 
anatomic site category of soft tissue, but let the 
user select a speciﬁ  c site for it. While this is satis-
factory from a taxonomic perspective, it would 
require the users to have a very high level of knowl-
edge of anatomy, diagnostic pathology, as well as 
the pathophysiology of all diseases. Speciﬁ  cally, 
tissue procurement personnel would need to learn 
which diseases are primary to a speciﬁ  c organ site 
(carcinomas) and which diseases can be found 
anywhere (e.g. most sarcomas). Further, they 
would need to be able to recognize those sarcomas 
that are speciﬁ  c to a site, e.g. malignant phyllodes 
tumor that is found only in the breast or have spe-
cial pathophysiologic characteristics such as angio-
sarcomas associated with the breast.
A decision was made to compromise here in 
order to ease the management of tissue collection 
and distribution by repository personnel who are 
not trained as pathologists. Thus, when inputting 
a tissue request for a type of sarcoma, the personnel 
do not need to know that the embryologic origin 
of this tumor is mesenchyme, all the sites where 
speciﬁ  c types of sarcomas arise, or special sarco-
mas that arise because of a speciﬁ  c condition (e.g. 
angiosarcoma of the breast). Even so, investigators 
may request a mesenchymal tumor from any soft 
tissue site, or may specify the site and then a tumor 
whose embryologic origin is mesenchymal or 
epithelial. In future versions of the system that 
include a concept based interface, users can be 
guided to select the appropriate disease categories 
via the search engine and a series of questions.
Using the same philosophy of compromise 
between a very granular, purely biologically 
deﬁ  ned system and a system that can be used by 
non-pathologists, the CHTN has combined hyper-
plasia and metaplasia with benign neoplasia as a 
subcategory of neoplastic disease, as well as dys-
plasia, premalignant tumors, and tumors of 
unknown malignant potential.
As stated earlier, the terminology for neoplastic 
disease is included in Appendix A. The adoption 
of a terminology for cancer diagnoses requires 
more discussion than the previous categories 
because of the desire to remain compliant with 
tissue banking tool development by caBIG.
Terminology for Neoplasia, 
Standards, and CaBIG
As of January 1, 2004, the American College of 
Surgeons (ACS) Commission on Cancer (CoC) 
mandated new standards for pathology reports, 
including standards for histopathological terminol-
ogy, through its certiﬁ  cation program. One new 
standard requires that pathologists at CoC-
approved cancer programs include all scientiﬁ  cally 
validated or regularly used data elements and their 
allowable values from the CAP Cancer Protocols 
checklists in their reports for each site and speci-
men. In order to comply with the ACS mandate, 
cancer programs are now expected to show that 90 
percent of pathology reports include all scientiﬁ  -
cally validated or regularly used elements of the 
appropriate checklists.
The CAP Cancer Protocols checklists for inva-
sive carcinomas, and where they are included, 
diseases of indeterminate malignancy were adopted 
by the CHTN as a starting basis for the neoplastic 
disease terminology. This is because CHTN per-
sonnel have ready access only to the surgical 
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pathology report that is tied to a speciﬁ  c tissue. 
The CAP Cancer Protocols and checklists have 
been assembled, organized, and approved by 
experts for the carcinomas. For soft tissue and bone 
tumors, the CAP has recently issued a protocol in 
which they refer the user to histopathological ter-
minology approved by the World Health Organiza-
tion terminology. The CHTN has also adopted the 
terminology approved by the World Health Orga-
nization for bone and soft tissue tumors.
In a limited number of instances, tissues have 
been requested for entities that are still considered 
controversial. In these instances, the literature was 
reviewed and nomenclature was selected that ful-
ﬁ  lled the following two criteria: it was proposed 
by experts, and it represented the most granular 
disease deﬁ  nition that was current.
By adopting the CAP protocols and checklists 
for malignant tissue requests, TissueQuest© at least 
includes terminology that is used by CaBIG for 
malignancy. The Tissue Banking and Pathology 
Tools Workspace of the Cancer Bioinformatics 
Grid effort has recently published a case study in 
which they demonstrated how the CAP reporting 
protocols for at least three cancer systems would 
be integrated into caCORE.
10 They concluded that 
“The CAP cancer checklists can be used as the 
basis for an electronic data standard in pathology 
using the caBIG semantic modeling methodology.” 
In addition, adoption of the CAP cancer protocols 
simpliﬁ  es the process of matching a tissue request 
to diagnostic terminology used by pathologists at 
institutions that are approved by the ACS. We 
propose that the main problem with this approach 
is that it ignores the educational level and lack of 
detailed training in pathology of those personnel 
(e.g. tissue resource personnel and investigators) 
who will be using the database.
The CAP checklists are adequate for the vast 
majority of frankly malignant or invasive carcino-
mas; however, they do not address pre-malignancies, 
most dysplasias, and benign tumors, nor do they 
consider non-neoplastic diseases (e.g. idiopathic 
pulmonary arterial hypertension). (Bone and soft 
tissue terminology is the same as that proposed by 
the WHO, as stated earlier). The CHTN has assem-
bled a terminology for these lesions using the 
approach described above for controversial lesions: 
the terminology 1) is used by experts in the ﬁ  eld and 
2) it can offer sufﬁ  cient granularity at the diagnosis 
level to deﬁ  ne tissue, with the caveat that proper 
names associated with a lesion should be avoided.
Conclusion
The CHTN was presented with a problem: the need 
for an informatics system for managing tissue 
requests that 1) would use histological deﬁ  nitions 
to annotate the tissue, 2) would be caBIG compliant 
within the domain of cancer tissues and diagnoses, 
and 3) that could be used by pathologists and and 
most importantly by non-pathologists. In order to 
structure this system, an ontology was built for 
disease classiﬁ  cation, and the tissue request system 
structure was built upon its backbone. Within the 
ontology, data elements were selected to supply 
the appropriate metadata for each tissue request. 
These were selected for compliance with caBIG 
as far as diagnostic data elements were concerned. 
However, additional data elements beyond the 
scope of those used by caBIG tools have also been 
introduced as needed. Some of these have been 
discussed here. The tools for collecting and storing 
information concerning actual tissue collection 
protocols will be discussed in detail in a subsequent 
publication describing TissueQuest© itself in more 
detail. Finally, a set of allowable terms for 
diagnostic histopathology for use by the CHTN 
was assembled based upon the data model for 
disease classiﬁ  cation. For malignant neoplasia, 
CAP terminology for carcinomas and WHO 
terminology for bone and soft tissue tumors has 
been adopted, supplemented as needed using 
terminology that has been accepted by experts in 
the ﬁ  eld if the terminology is not included in CAP 
protocols for carcinomas or WHO protocols for 
bone and soft tissue tumors, but is sufﬁ  ciently 
granular to deﬁ  ne a histopathological diagnosis, 
including the caveat that entities with proper names 
are minimized.
This ontological structure provides a number of 
advantages. A search engine has been superim-
posed on it so that personnel can search by organ 
site, disease class, or disease name, and they will 
be returned a list of options to choose from. A 
particular option can be selected and will pre-ﬁ  ll 
a tissue request with the information contained 
within the selection. This search engine will be 
further enhanced with maps to other vocabularies 
and to NCI/CaBIG approved concepts. In addition, 
a concept based interface that guides users using 
a decision tree overlaid on the ontology developed 
here is planned for the future. It is anticipated that 
this kind of interface will make this tool amenable 
to investigators from a broad range of educational 
backgrounds.
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The CHTN also plans to submit its data elements 
and allowable values to the Cancer Data Standards 
Repository (CaDSR) so that they can be used to 
extend the domain of tissue procurement currently 
deﬁ  ned by caTissue, an archival based tissue inven-
tory system supported by caBIG. In addition to 
metadata for deﬁ  ning tissue procurement protocols, 
the ontology and terminology for diseases not 
included in the domain of caBIG are included here 
for use by the tissue collection community.
Because malignancy of the breast is relatively 
complicated, several examples of how requests for 
such tissue would be handled by our vocabulary 
system are described as follows:
1) An investigator requests breast cancer. The 
investigator is contacted to determine if a spe-
cial type (e.g. ductal, lobular, tubular etc.) is 
requested. If the investigator wants any carci-
noma, a very common request, the terminology 
used would be breast, invasive carcinoma, 
(NOS).  The coordinator can either generate a 
Malignant tissue request and select these values 
via the drop-down lists for anatomic site and 
histologic diagnosis, or use the search engine 
to search the selections for a malignant breast 
tissue request using the keywords “malignant” 
and “breast”. (The search engine defaults to the 
Boolean operator AND to minimize the selec-
tions that it retrieves.). The coordinator selects 
Breast-Invasive Carcinoma (NOS), and a tissue 
request form is generated that has been auto-
matically populated with these terms for the 
anatomic site and histologic type.
2)  If the investigator speciﬁ  ed only primary muci-
nous breast carcinoma tissue, the tissue request 
type would be malignant and the anatomic site 
and histologic type would be breast and muci-
nous.  As above, these could be entered on a 
malignant tissue request page, or a malignant 
tissue request page populated with these values 
for anatomic site and histologic type could be 
generated via the search engine. The coordina-
tor would request Primary Anatomic Site as the 
tissue type requested by the user. 
3)  If an investigator requested tubular carcinomas 
from African-Americans between 20 and 50 
years of age, but only metastases to lymph nodes 
(any site) was needed, the malignant tissue 
request could be generated via the search engine 
as described above.  For tissue type, the coor-
dinator would select Metastasis and would 
choose lymph nodes-any as the tissue site.     
There is an option to specify age range, gender, 
and race/ethnicity on the tissue request page.
In summary, the CHTN has developed a vocab-
ulary system with an associated search engine that 
is user friendly and is easily used by personnel with 
varying educational backgrounds and without 
extensive training in diagnostic pathology or a 
related ﬁ  eld. This vocabulary and associated search 
engine is available at no cost via requests submit-
ted to the CHTN Central coordinator: 
chtncentral@earthlnk.net.
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